Skip to content

Visualmed

Clinical trials summarized as Visual Abstracts

Menu
  • Submit Article
  • About
  • Private Policy
  • Visualmed App for iphone
  • Visualmed App for Android
  • List of Clinical Trials

TECOS Trial: Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes

by adminPosted onMay 2, 2020July 24, 2020
Posted in Cardiovascular Disease, EndocrinologyTagged CV outcomes, diabetes, sitagliptin, type 2 diabetes

Post navigation

Prev TARGET Trial: Energy-Dense versus Routine Enteral Nutrition in the Critically Ill
Next THEMIS PCI Trial: Ticagrelor in patients with diabetes and CAD with a history of PCI

Subscribe via Email

Select list(s)*

 

Loading
Amphibious Theme by TemplatePocket ⋅ Powered by WordPress